Shanghai Sanyou Medical Co Ltd - Asset Resilience Ratio
Shanghai Sanyou Medical Co Ltd (688085) has an Asset Resilience Ratio of 7.69% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how Shanghai Sanyou Medical Co Ltd's Asset Resilience Ratio has changed over time. Check 688085 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Shanghai Sanyou Medical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Shanghai Sanyou Medical Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥180.23 Million | 7.69% |
| Total Liquid Assets | CN¥180.23 Million | 7.69% |
Asset Resilience Insights
- Limited Liquidity: Shanghai Sanyou Medical Co Ltd maintains only 7.69% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shanghai Sanyou Medical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shanghai Sanyou Medical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM |
Medical Devices | 46.67% |
|
Allmed Solutions Ltd
TA:ALMD |
Medical Devices | 80.03% |
|
Universal Biosensors Inc
AU:UBI |
Medical Devices | 14.72% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Annual Asset Resilience Ratio for Shanghai Sanyou Medical Co Ltd (2020–2024)
The table below shows the annual Asset Resilience Ratio data for Shanghai Sanyou Medical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.18% | CN¥50.23 Million ≈ $7.35 Million |
CN¥2.31 Billion ≈ $337.54 Million |
+1.31pp |
| 2023-12-31 | 0.87% | CN¥19.63 Million ≈ $2.87 Million |
CN¥2.26 Billion ≈ $330.93 Million |
-7.94pp |
| 2022-12-31 | 8.81% | CN¥193.10 Million ≈ $28.26 Million |
CN¥2.19 Billion ≈ $320.67 Million |
-10.05pp |
| 2021-12-31 | 18.86% | CN¥376.63 Million ≈ $55.11 Million |
CN¥2.00 Billion ≈ $292.25 Million |
-33.85pp |
| 2020-12-31 | 52.71% | CN¥880.65 Million ≈ $128.87 Million |
CN¥1.67 Billion ≈ $244.47 Million |
-- |
About Shanghai Sanyou Medical Co Ltd
Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system… Read more